In clinical trials, brain monitoring EEG is facilitating the measurement of complex clinical endpoints. EEG as a biomarker provides safe, objective and repeatable data enabling a deeper understanding of the pharmacological effects of the drug early in its development.
The benefits of collecting EEG neuroimaging insights in clinical trials.
The capacity of neurotechnologies to probe and interfere with brain activity challenges notions of identity, integrity and autonomy of human being. Recent initiatives aim to help actors in the field anticipate and address ethical, legal and social challenges, while promoting innovation in this area.
Cutting edge “neuro-IA” technologies can detect the physiological impact of a cosmetic product using real-time consumers’ emotional data collected from the brain, in order to deploy a plethora of quantitative information to be used at both the conception and application stage of one product journey.
Neuroergonomics provides a multidisciplinary approach that merges elements of neuroscience, human factors, and ergonomics to study brain response to stimuli. The main goal is to utilise new types of neurotechnologies in order to create better symbiosis between a product itself, the human experience, and its environment.
On Tuesday, November 16, 2021, at 11am, come and listen to Giuseppe Spinelli at the microphone of Pascal Becache on the occasion of the 4th Webinar #PharmaTalk of Digital Pharma Lab. Accompanied by Antoine Groheux, they will discuss about "AI, conquering emotions in Health!".
Neuroscience and artificial intelligence are about to revolutionize medicine, especially psychiatry. Neurotechnologies offer a range of new tools based on objective and empirical data which will revolutionize the diagnosis and prevention of psychiatric pathologies.